image
Healthcare - Medical - Instruments & Supplies - NASDAQ - US
$ 15.825
-0.634 %
$ 3.15 B
Market Cap
-3.51
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jul, 21, 2025.

The intrinsic value of one XRAY stock under the worst case scenario is HIDDEN Compared to the current market price of 15.8 USD, DENTSPLY SIRONA Inc. is HIDDEN

This DCF valuation model was last updated on Jul, 21, 2025.

The intrinsic value of one XRAY stock under the base case scenario is HIDDEN Compared to the current market price of 15.8 USD, DENTSPLY SIRONA Inc. is HIDDEN

This DCF valuation model was last updated on Jul, 21, 2025.

The intrinsic value of one XRAY stock under the best case scenario is HIDDEN Compared to the current market price of 15.8 USD, DENTSPLY SIRONA Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart XRAY

image
$20.0$20.0$19.0$19.0$18.0$18.0$17.0$17.0$16.0$16.0$15.0$15.0$14.0$14.0$13.0$13.0$12.0$12.0Feb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '2515 Jun15 JunJul '25Jul '2515 Jul15 Jul
FINANCIALS
3.79 B REVENUE
-4.34%
-879 M OPERATING INCOME
-934.12%
-910 M NET INCOME
-589.39%
461 M OPERATING CASH FLOW
22.28%
-197 M INVESTING CASH FLOW
-121.35%
-302 M FINANCING CASH FLOW
1.63%
879 M REVENUE
-2.87%
63 M OPERATING INCOME
112.38%
19 M NET INCOME
104.42%
7 M OPERATING CASH FLOW
-91.95%
-17 M INVESTING CASH FLOW
70.18%
123 M FINANCING CASH FLOW
423.68%
Balance Sheet DENTSPLY SIRONA Inc.
image
Current Assets 1.75 B
Cash & Short-Term Investments 272 M
Receivables 606 M
Other Current Assets 868 M
Non-Current Assets 4.01 B
Long-Term Investments 0
PP&E 902 M
Other Non-Current Assets 3.1 B
4.73 %10.53 %15.09 %15.68 %53.97 %Total Assets$5.8b
Current Liabilities 1.59 B
Accounts Payable 241 M
Short-Term Debt 595 M
Other Current Liabilities 753 M
Non-Current Liabilities 2.22 B
Long-Term Debt 1.68 B
Other Non-Current Liabilities 544 M
6.33 %15.62 %19.76 %44.02 %14.28 %Total Liabilities$3.8b
EFFICIENCY
Earnings Waterfall DENTSPLY SIRONA Inc.
image
Revenue 3.79 B
Cost Of Revenue 1.84 B
Gross Profit 1.96 B
Operating Expenses 2.84 B
Operating Income -879 M
Other Expenses 31 M
Net Income -910 M
4b4b4b4b3b3b3b3b2b2b2b2b1b1b500m500m00(500m)(500m)(1b)(1b)4b(2b)2b(3b)(879m)(31m)(910m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
51.62% GROSS MARGIN
51.62%
-23.17% OPERATING MARGIN
-23.17%
-23.99% NET MARGIN
-23.99%
-46.86% ROE
-46.86%
-15.82% ROA
-15.82%
-17.96% ROIC
-17.96%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis DENTSPLY SIRONA Inc.
image
600m600m500m500m400m400m300m300m200m200m100m100m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -910 M
Depreciation & Amortization 349 M
Capital Expenditures -180 M
Stock-Based Compensation 39 M
Change in Working Capital 95 M
Others 1.03 B
Free Cash Flow 281 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets DENTSPLY SIRONA Inc.
image
Wall Street analysts predict an average 1-year price target for XRAY of $17.7 , with forecasts ranging from a low of $14 to a high of $20 .
XRAY Lowest Price Target Wall Street Target
14 USD -11.53%
XRAY Average Price Target Wall Street Target
17.7 USD 11.64%
XRAY Highest Price Target Wall Street Target
20 USD 26.38%
Price
Max Price Target
Min Price Target
Average Price Target
282826262424222220201818161614141212Sep '24Sep '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26
4. DIVIDEND ANALYSIS
1.08% DIVIDEND YIELD
0.16 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
0.70000.70000.60000.60000.50000.50000.40000.40000.30000.30000.20000.20000.10000.10000.00000.00000.0720.07750.08750.08750.08750.10.10.1250.140.160.160.07250.07750.08750.08750.08750.10.110.1250.140.160.160.07250.07750.08750.08750.10.10.110.1250.140.160.07250.290.07750.310.08750.350.08750.350.10.380.10.400.110.430.1250.500.140.560.160.640.322015201520162016201720172018201820192019202020202021202120222022202320232024202420252025
Download SVG
Download PNG
Download CSV
5. COMPETITION
slide 2 of 11
6. Ownership
Insider Ownership DENTSPLY SIRONA Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
250 K USD 1
3-6 MONTHS
421 K USD 2
6-9 MONTHS
200 K USD 1
9-12 MONTHS
7. News
Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer Provides Select Preliminary Second Quarter 2025 Results and Reaffirms 2025 Outlook Provides Select Preliminary Second Quarter 2025 Results and Reaffirms 2025 Outlook globenewswire.com - 4 days ago
XRAY vs. MMSI: Which Stock Is the Better Value Option? Investors interested in Medical - Dental Supplies stocks are likely familiar with Dentsply International (XRAY) and Merit Medical (MMSI). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com - 1 week ago
Are Investors Undervaluing Dentsply Sirona (XRAY) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com - 1 week ago
Reasons to Add DENTSPLY SIRONA Stock to Your Portfolio Now XRAY gains traction with digital implants, R&D strength, and Q1 margin growth despite softness in Europe. zacks.com - 1 week ago
Dental 3D Printing Market Forecast Study 2025, with Leading Dental Companies and Innovators BEGO, Dentsply Sirona, WhipMix, Straumann, Ivoclar, Formlabs, SprintRay, Asiga, and Shining3D Explore the latest dental 3D printing market trends. Discover insights into dental segment growth, technological adoption, and 2024 revenue data of $5.2B. The market is poised to nearly double by 2033. Explore the latest dental 3D printing market trends. Discover insights into dental segment growth, technological adoption, and 2024 revenue data of $5.2B. The market is poised to nearly double by 2033. globenewswire.com - 1 week ago
Dentsply Sirona to Host Second Quarter Conference Call on August 7th CHARLOTTE, N.C., July 10, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, August 7, 2025, at 8:30 am ET to review its financial results for the second quarter of fiscal year 2025. The Company will issue a press release and provide a presentation with summary financial information, which will be made available on the Investors section of the Company's website at https://investor.dentsplysirona.com prior to the call. globenewswire.com - 2 weeks ago
Why Dentsply International (XRAY) is a Top Momentum Stock for the Long-Term The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. zacks.com - 2 weeks ago
Why Dentsply International (XRAY) is a Top Value Stock for the Long-Term Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com - 3 weeks ago
XRAY or MMSI: Which Is the Better Value Stock Right Now? Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Dentsply International (XRAY) and Merit Medical (MMSI). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com - 3 weeks ago
Is Dentsply Sirona (XRAY) Stock Undervalued Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com - 3 weeks ago
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Shareholders to Learn More About the Investigation NEW YORK CITY, NY / ACCESS Newswire / June 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com - 1 month ago
XRAY vs. MMSI: Which Stock Is the Better Value Option? Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Dentsply International (XRAY) or Merit Medical (MMSI). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com - 1 month ago
8. Profile Summary

DENTSPLY SIRONA Inc. XRAY

image
COUNTRY US
INDUSTRY Medical - Instruments & Supplies
MARKET CAP $ 3.15 B
Dividend Yield 1.08%
Description DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.
Contact 13320 Ballantyne Corporate Place, Charlotte, NC, 28277-3607 https://www.dentsplysirona.com
IPO Date Aug. 12, 1987
Employees 14000
Officers Mr. Simon D. Campion Chief Executive Officer, President & Director Mr. Herman V. Cueto Interim Chief Financial Officer Mr. Kevin Boyle Senior Vice President & Chief Technology Officer Mr. David Ferguson Senior Vice President of Global Business Unit Leader Mr. Richard C. Rosenzweig J.D. Executive Vice President of Corporate Development, General Counsel & Secretary Mr. Robert Anthony Johnson Senior Vice President & Chief Supply Chain Officer and Head of Sustainability Ms. Andrea L. Frohning Senior Vice President & Chief Human Resources Officer Ms. Andrea Daley Vice President of Investor Relations Mr. Kevin J. Czerney Vice President & Chief Accounting Officer Ms. Emily P. Miner Senior Vice President of Global Quality and Regulatory & Chief Quality Officer